These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6821455)

  • 1. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
    Rella M; Haas D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):242-9. PubMed ID: 6821455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
    Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Robillard NJ; Scarpa AL
    Antimicrob Agents Chemother; 1988 Apr; 32(4):535-9. PubMed ID: 2837141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    Hane MW; Wood TH
    J Bacteriol; 1969 Jul; 99(1):238-41. PubMed ID: 4895844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Hirai K; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):582-6. PubMed ID: 3111356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
    Duval J; Soussy CJ
    Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa.
    Fyfe JA; Govan JR
    J Gen Microbiol; 1984 Apr; 130(4):825-34. PubMed ID: 6429275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.
    Aisa ML; Omenaca M; Bergua C; Garcia-Moya JB
    Infection; 1982; 10 Suppl 3():S244-8. PubMed ID: 6818157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of chlorpromazine and perphenazine on several chemotherapeutic agents. I. General profile of the effects measured by the filter paper strip-agar diffusion method with Escherichia coli and Pseudomonas aeruginosa.
    Yamabe S
    Chemotherapy; 1978; 24(2):81-6. PubMed ID: 145936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gyrase (Topoisomerase II) from Pseudomonas aeruginosa.
    Miller RV; Scurlock TR
    Biochem Biophys Res Commun; 1983 Jan; 110(2):694-700. PubMed ID: 6301461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
    Yamagishi J; Furutani Y; Inoue S; Ohue T; Nakamura S; Shimizu M
    J Bacteriol; 1981 Nov; 148(2):450-8. PubMed ID: 6271730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
    Downs J; Andriole VT; Ryan JL
    Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferable resistance to specific antibiotics in nosocomial strains of Pseudomonas aeruginosa from two teaching hospitals.
    Blahová J; Králiková K; Krcméry V; Schäfer V; Torsová V
    J Chemother; 1996 Dec; 8(6):420-4. PubMed ID: 8981181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
    Sugino A; Peebles CL; Kreuzer KN; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4767-71. PubMed ID: 200930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nalidixic acid and novobiocin on pBR322 genetic expression in Escherichia coli minicells.
    Gómez-Eichelmann MC
    J Bacteriol; 1981 Dec; 148(3):745-52. PubMed ID: 7031033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of gentamicin resistance from Pseudomonas aeruginosa strains highly resistant to gentamicin and carbenicillin.
    Knothe H; Krcméry V; Sietzen W; Borst J
    Chemotherapy; 1973; 18(4):229-34. PubMed ID: 4633009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.